Allergy Treatment Market, By Type (Eye Allergy, Asthma, Rhinitis, Skin Allergy, Food Allergies, and Others), By Treatment (Anti-allergy Drugs and Immunotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024

Code : CMI5143

Pages :170

Formats :

Excel and PDF

Industry : Pharmaceutical

Allergy Treatment Market Size and Trends

The global allergy treatment market is estimated to be valued at USD 21.19 Bn in 2024 and is expected to reach USD 34.42 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

Allergy Treatment Market Key Factors

To learn more about this report, request sample copy

The global allergy treatment market is witnessing positive trends with rising environmental pollution levels and growing adoption of sedentary lifestyle among people worldwide. Increased air pollution along with higher consumption of fast food and processed food has significantly contributed to the increased prevalence of allergies. Additionally, market players are continuously focusing on developing advanced and effective drugs for treating diverse allergy conditions such as asthma, rhinitis, conjunctivitis, and others. Several pipeline drugs for treating chronic allergic diseases are expected to enter the market soon, thereby propelling the overall growth of the industry during the forecast period

Increasing Availability of Allergen Immunotherapy Solutions

The increasing availability of allergen immunotherapy solutions is one of the factors that is expected to drive the market growth during the forecast period. For instance, in June 2021, Stallergenes Greer, one of the global leaders in allergy immunotherapy, announced that the Alusta, subcutaneous allergen immunotherapy (SCIT) solution for different allergies involving rhinitis, conjunctivitis, rhino conjunctivitis, or asthma is now available in Spain and Italy.

/p>Increasing Inorganic Growth Strategies by Key Market Players

Increasing adoption of inorganic growth strategies, such as collaborations, is expected to drive the market growth over the forecast period. For instance, on January 8, 2024, Inimmune Corporation, a pharmaceutical company, and Intrommune Therapeutics, Inc., a clinical-stage company focused on the development of innovative immunotherapeutics, announced that they had collaborated together to advance a revolutionary rapid, long-acting oral mucosal allergy immunotherapy for the treatment of peanut allergy.